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Direct Recommendation for HPV Vaccination 
Danielle Bogue, MSN, FNP-BC 
Introduction of the Problem 
The Centers for Disease Control (CDC) currently recommends HPV vaccination for 
adolescents ages 9 to 26 years old.  Despite these recommendations, many adolescents in a 
suburban Midwest clinic were unvaccinated or under-vaccinated. There were no standard 
procedures among providers for patient, parent, and guardian education, nor a standard protocol 
for initiating the HPV vaccine.   
Review of the Literature 
 Avoidance of any sexual contact with another person can prevent an HPV infection.  
Should intimate contact be unavoidable or unpredictable, HPV prevention is available through 
vaccination (Meites, Kempe, & Markowitz, 2016).  This option of vaccination prevents HPV 
infection and decreases the chance of unknowingly transmission (Steban, 2007).  
 Parental knowledge about HPV and the HPV vaccine may be insufficient for parents to 
make informed decisions about HPV vaccination.  Lack of knowledge has been identified as one 
cause of HPV declination (Dempsey et al., 2006). Sources of available information for parents 
may not be reliable or reputable and HPV has not been publicly identified as a risk for children 
of all ages (Woodhall et al., 2007).  Lack of familiarity may be related to fewer healthcare office 
visits for healthy children at mandated times of kindergarten, sixth, and ninth grades (Reagan-
Steiner et al., 2015).  Teaching about HPV and offering recommended vaccines should be 
addressed at each visit (Smith et al., 2016). 
 HPV is not a reportable illness in the United States.  Therefore, current literature 
regarding male HPV statistics are scarce.  The average annual incidences of male HPV-
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associated cancers in Illinois are estimated at 9.9 per 100,000 cases overall (Viens et al., 2016).  
The transfer of HPV does not have to include penetrative behaviors. HPV infections are 
generally asymptomatic, which increases the burden of HPV infection with men who have sex 
with men (MSM) (Public Health Agency of Canada, 2013).    
 Evidence exists that parents are concerned about side effects and the safety profile of the 
HPV vaccine.  In a recent study of Latino parents, many assumed the HPV vaccine was 
dangerous and expressed a high level of concern regarding adverse effects; parents often feared 
false adverse reaction, such as infertility, irregular menstruation, behavioral issues, and death 
(Warner et al., 2015).  Among a total of more than 15,000 adolescents who received at least one 
dose of the 9vHPV vaccine in clinical trials, only 0.1% discontinued vaccination due to adverse 
reactions (Moreira et al., 2016).  Meites (2016) determined the 9vHPV vaccine was effective 
with > 97.9% seroconversion to all nine vaccine-preventable HPV types by four weeks after the 
last dose.  .  
 Parental belief that the HPV immunization isn’t necessary because the adolescent hasn’t 
engaged in sexual behaviors has prevented vaccination in favorable adolescents (Obulaney et al., 
2016).  In fact, there exists a parental belief that consenting to the vaccine will imply parental 
consent for adolescent sexual behavior (Beavis and Levinson, 2016).  No data exists to support 
that theory (Grimes et al., 2013).  Vaccination against HPV is necessary prior to any sexual 
encounter (McKeage & Lyseng-Williamson, 2016), because 9vHPV is a preventive measure, not 
a treatment. 
 HPV information presented by a healthcare provider was found to be a strong predictor of 
intent to vaccinate (Dempsey et al., 2006). However, consistency of provider recommendation 
towards the HPV vaccine is lacking (Smith et al., 2016).  Strong recommendations from the 
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provider as well as the belief that a child is at risk for contracting HPV increases parental consent 
for the HPV vaccination (Horn, Howard, Waller & Ferris, 2010).    
Project Methods 
The goal of this project was to increase HPV vaccination acceptance rates by focusing on 
provider actions of education and strong recommendation to parents and guardians of 
adolescents ages 9-17 years old and adults ages 18-26 years old.  A convenience sample of 
individuals seen at a family practice office in Illinois over a six-week period during the months 
of June and July 2018 was obtained. A proposal to conduct research involving human subjects 
entitled “Human Subjects DNP Project,” was submitted and reviewed by the Institutional 
Review Board (IRB) at Southern Illinois University Edwardsville and found to be exempt from 
IRB review on April 10, 2018.   
An informal meeting highlighting the project was presented to providers, nurses, medical 
assistants, receptionist and the office coordinator in early May 2018. Clinical significance as well 
as purpose of preventing HPV was reviewed. A handout titled "Talking to Parents About HPV 
Vaccine" was given to providers and staff. Common questions from parents and example 
responses to topics such as risk of HPV, vaccine safety, vaccine efficacy were discussed and 
reviewed. Visual reminders with wall clings to remind staff to ask families about HPV 
vaccination were placed in patient rooms. The guidelines, age recommendation, and dosing 
schedules were made readily available for providers and staff. 
A new procedure for HPV vaccination was implemented in June and July 2018.  
Guardians of patients under 18 years old or adult patients who were eligible for HPV vaccination 
were presented with a short video and handout on HPV by the medical assistant. This video was 
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provided prior to the visit with the provider. In addition, a two-minute conversational 
recommendation was provided. 
At the end of the patient's visit, a Post Intervention Plan was completed by the guardian 
or adult patient and placed in one of two lock boxes at check-out.  The form asked to indicate 
one the following options; accept the 9vHPV vaccine, refuse to vaccinate with the 9vHPV, 
vaccine for kids (VFC) eligible, and received the vaccine today. Data was reviewed at the end of 
the 6-week project.  Qualitative data was received through small focus groups with staff and 
providers conducted one week after project implementation.  Focus group discussion centered on 
questions to determine how practices changed after project initiation, how parents and patients 
received HPV education, and reasons provided for accepting or declining HPV vaccination. Staff 
and providers were asked to provide suggestions for future sustainability of the project. Similar 
responses obtained from the focus session were grouped and evaluated on the basis of provider 
and staff feelings regarding the HPV intervention. 
Evaluation 
Thirty-three patients met criteria for inclusion in this project.  Inclusion criteria was 
determined as an individual between the ages of 9-26 years old, no previous HPV vaccinations, 
and parent/guardian was present for consent.  No one declined participation.  Of the 35 
participants, 33 accepted the HPV vaccine and 2 refused the vaccine.  Reasoning for decline was 
the desire to include the children’s other parent in the decision-making process. Seventeen 
patients received their HPV vaccine while another ten planned to get vaccinated, but are VFC 
eligible and will obtain from the health department.  Eight participants who accepted the vaccine 
did not receive the vaccine the same day. Stated reasons included fear of arm pain which may 
affect ability to play sports and vaccine out of stock.  
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A focus group was held one week after project completion.  Two providers completed the 
post-intervention questionnaire and two medical assistants gave commentary regarding the 
sustainability for the future.  Office staff were supportive and engaged in identifying eligible 
participants.  Simple reminders posted assisted in identifying appropriate candidates.  Parents 
and guardians gave positive feedback to staff stating they appreciated the time spent educating 
about a vaccine to prevent cancer. One parent asked the provider why this project wasn’t done 
sooner because her older children were not vaccinated against HPV.  Despite efforts to make 
project interventions efficient, occasionally project implementation added several minutes to 
patient visit time.    
During this intervention, both providers decided to have earlier discussions with parents 
regarding prevention of HPV starting at the age of 9 years old, instead of waiting for the 
American Pediatric Associations recommendation of 11-12 years old (Meites et al., 2016). The 
providers thought this would capture more adolescents in need of vaccination against HPV.  
Future sustainability with providers giving a strong recommendation towards the HPV 
vaccination was a common agreement amongst all staff.  Medical assistants perceived this 
project a success and parents were receptive to teachings and recommendations.  The office 
continues with the medical assistant providing a handout, a 2-minute question/answer session 
with provider and parent/adult, and the provider making a strong recommendation.  However, the 
short video was eliminated due to time constraints.       
Impact on Practice  
Multiple practice improvements were made with the implementation of this DNP project.   
The manner in which HPV vaccines are introduced to patients has changed.  Medical assistants 
are proactive at reviewing immunization history at all visits and anticipate vaccinations needed.  
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Suggestions are reported to the provider prior to the provider entering the exam room.  Instead of 
providers asking if patients are coming for their vaccinations, they now state the vaccines due.  
Delivery of information is with eye contact, audible voice, and clear direct words.  This is 
referred to as a “strong provider recommendation”. 
Future plans include expansion of this educational intervention to other offices within the 
corporation.  By expanding the population, more adolescents will be educated and provided a 
strong recommendation towards HPV vaccination. This process will need to follow a similar 
method of educating the staff and providers at each facility, thorough training for the medical 
staff, and support of the intervention from management as well as the technical department.  The 
technical department should place the informative HPV video on the company’s intranet for easy 
access and viewability. 
Limitations of this project included lack of access to the clinic’s intranet to play the 
informational video and inability to track receipt of HPV vaccine for Medicaid patients. 
Approval of the video to be accessed on the company intranet required multiple larger health 
organization intranet permissions.  Therefore, a personal tablet had to be utilized with a mobile 
phone hot spot.  At the time of this project, the state of Illinois was not reimbursing or paying the 
cost of immunizations therefore, patients with state funded Medicaid managed care plans did not 
receive HPV vaccine from the clinic and were referred to the county health department making 
tracking receipt of the HPV vaccine for this population impossible.   Clinics who replicate this 
project should research their organization’s intranet and computer systems policies.  The impact 
of the project on Medicaid populations is somewhat unclear due to the inability to track receipt 
of vaccination for these patients. 
Conclusions 
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The reality and prevalence of HPV is undeniable.  Its presence lies within a large age 
group and risk of HPV infection increases with age.  Providers and health care personnel can 
help prevent the incidence of HPV in adolescents ages 9-26 years old with the initiation of HPV 
vaccination. Presentation of information is best understood when utilizing multiple senses such 
as visual and audio, and reinforced with a strong provider recommendation.  If we can’t stop it, 
let’s prevent it.       
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